Mike Robson

Peter Callan2
Eugene Athan2
Anthony McDonald2
2Peter Callan
2Eugene Athan
2Anthony McDonald
Learn More
BACKGROUND The World Health Organization currently recommends combined streptomycin and rifampicin antibiotic treatment as first-line therapy for Mycobacterium ulcerans infections. Alternatives are needed when these are not tolerated or accepted by patients, contraindicated, or neither accessible nor affordable. Despite in vitro effectiveness, clinical(More)
BACKGROUND Paradoxical reactions from antibiotic treatment of Mycobacterium ulcerans have recently been recognized. Data is lacking regarding their incidence, clinical and diagnostic features, treatment, outcomes and risk factors in an Australian population. METHODS Data was collected prospectively on all confirmed cases of M. ulcerans infection managed(More)
  • 1